AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans

Israa M. Shamkh(R2M Solution (Italy)), Amr Ahmed(Ministry of Health), Reem M. Aljowaie(King Saud University), Moayad Shahwan(Ajman University), Mahmoud Elkazzaz(Damietta University), Saeedah Musaed Almutairi, Mohammad Shahbaz Khan(Children's National), Basit Jabbar(University of the Punjab), Abdullah Haikal(Mansoura University), Md Tabish Rehman(King Saud University), Enas S. Radwan(Zarqa University), Muhammad Sufyan(Government College University, Faisalabad), Tomasz M. Karpiński(Poznan University of Medical Sciences), Mohamed F. Alajmi(King Saud University), Nouf K. Alaqeel(Damietta University), Ibrahim A. Ibrahim(Damietta University), Jawayria Najeeb(University of Gujrat)
Current Pharmaceutical Design
September 1, 2023
Cited by 5


Related Papers